Sponsored
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posted
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
UAE: Dubai to introduce universal icons to expose levels of human and AI contribution in writing and content creation
Dubai has launched the world’s first Human–Machine Collaboration (HMC) Icons system...
‘Media frenzy’: Influencer Emilie Kiser’s husband may face felony charges after son drowned in pool; could be imprisoned for over 3 years
Brady Kiser, husband of social media influencer Emilie Kiser, might be charged. This follows the...